ORTIN GLOBAL LIMITED vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of ORTIN GLOBAL LIMITED (ORTINGLOBE) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads ORTINGLOBE vs SUNPHARMA on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability04
- Growth01
- Size & financial health04
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SUNPHARMA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 4/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Debtor days have improved from 260 to 178 days."]
- − ["Stock is trading at 9.79 times its book value", "Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -45.0% over past five years.", "Promoter holding is low: 1.23%", "Company has a low return on equity of -72.7% over last 3 years.", "Contingent liabilities of Rs.24.3 Cr.", "Company might be capitalizing the interest cost", "Company has high debtors of 178 days.", "Promoter holding has decreased over last 3 years: -6.13%"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.